FDA releases additional doses of Moderna’s COVID-19 booster amid shortages

Published



The Food and Drug Administration is releasing additional doses of Moderna’s omicron-specific COVID-19 boosters that were previously withheld from the government’s initial rollout earlier this month while the agency conducted safety inspections at an Indiana packaging plant.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.